These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 826958)

  • 1. Sleep: effects of d- and l-amphetamine in man and in rat.
    Hartmann E; Cravens J
    Psychopharmacology (Berl); 1976 Nov; 50(2):171-5. PubMed ID: 826958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy.
    Kanbayashi T; Honda K; Kodama T; Mignot E; Nishino S
    Neuroscience; 2000; 99(4):651-9. PubMed ID: 10974428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the L-DOPA and (+)-amphetamine-induced waking EEG in the rat.
    Monti JM
    Br J Pharmacol; 1979 Sep; 67(1):87-91. PubMed ID: 40644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons.
    Bunney BS; Walters JR; Kuhar MJ; Roth RH; Aghajanian GK
    Psychopharmacol Commun; 1975; 1(2):177-90. PubMed ID: 1223998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

  • 6. Amphetamine: differentiation by d and l isomers of behavior involving brain norepinephrine or dopamine.
    Taylor KM; Snyder SH
    Science; 1970 Jun; 168(3938):1487-9. PubMed ID: 5463064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic and noradrenergic substrates of positive reinforcement: differential effects of d- and l-amphetamine.
    Phillips AG; Fibiger HC
    Science; 1973 Feb; 179(4073):575-7. PubMed ID: 4686463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure and heart rate responses evoked by d- and l-amphetamine in the pithed rat preparation.
    Simpson LL
    J Pharmacol Exp Ther; 1975 Apr; 193(1):149-59. PubMed ID: 1133761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
    Tseng LF; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):717-24. PubMed ID: 4858403
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary excretion of epinephrine, norepinephrine, dopamine and tryptamine during sleep and wakefulness. Effects of pentobarbital, pentobarbital plus dextroamphetamine sulfate, and placebo.
    Baekeland F; Schenker VJ; Schenker AC; Lasky R
    Psychopharmacologia; 1969; 14(5):359-70. PubMed ID: 4900735
    [No Abstract]   [Full Text] [Related]  

  • 11. Sleep deprivation deficits and their reversal by d- and l-amphetamine.
    Hartmann E; Orzack MH; Branconnier R
    Psychopharmacology (Berl); 1977 Jul; 53(2):185-9. PubMed ID: 408844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine.
    Engber TM; Dennis SA; Jones BE; Miller MS; Contreras PC
    Neuroscience; 1998 Dec; 87(4):905-11. PubMed ID: 9759978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG.
    Chapotot F; Pigeau R; Canini F; Bourdon L; Buguet A
    Psychopharmacology (Berl); 2003 Mar; 166(2):127-38. PubMed ID: 12552359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of d- and l-amphetamine on food intake: evidence for a dopaminergic substrate.
    Evans KR; Vaccarino FJ
    Pharmacol Biochem Behav; 1987 Aug; 27(4):649-52. PubMed ID: 3659091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midbrain dopamine neurons: differential responses to amphetamine isomers.
    Browder S; German DC; Shore PA
    Brain Res; 1981 Mar; 207(2):333-42. PubMed ID: 7470912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulus properties of d-amphetamine as compared to l-amphetamine.
    Schechter MD
    Eur J Pharmacol; 1978 Feb; 47(4):461-4. PubMed ID: 631192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine.
    Arnold EB; Molinoff PB; Rutledge CO
    J Pharmacol Exp Ther; 1977 Sep; 202(3):544-57. PubMed ID: 894521
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 19. Similar potency ratios of amphetamine optical isomers for inhibition of dopamine uptake by synaptosomes of corpus striatum, olfactory tubercle and prefrontal cortex of the rat.
    Matthews RT; Shore PA
    Biochem Pharmacol; 1984 Sep; 33(17):2817-9. PubMed ID: 6466390
    [No Abstract]   [Full Text] [Related]  

  • 20. Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine.
    Herberg LJ; Stephens DN; Franklin KB
    Pharmacol Biochem Behav; 1976 May; 4(5):575-82. PubMed ID: 133356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.